Author:
Norman Robert A.,Young Edward M.
Reference7 articles.
1. Hope-Simpson RE. The nature of herpes zoster: a long term study and a new hypothesis. Proc R Soc Med. 1965;58:9–20.
2. Mahalingam R, Wellish M, Wolf W, Dueland AN, Cohrs R, Vafai A, et al. Latent varicella zoster viral DNA in human trigeminal and thoracic ganglia. N Engl J Med. 1990;323:627–31.
3. Whitley RJ. Varicella zoster. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2004.
4. Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology. 2004;62:1545–51.
5. Davies L, Cossins L, Bowsher D, Drummond M. The cost for treatment of post-herpetic neuralgia in the UK. Pharmacoeconomics. 1994;6:142–8.